Literature DB >> 8826137

Wound care nurses' judgements on healing time in chronic wounds.

B M Bates-Jensen.   

Abstract

With the current push to develop critical pathways for chronic wound patients, information on "normal" versus problematic wound healing is important. This descriptive study begins to define chronic wound healing time markers by examining clinicians' own healing expectations with pressure ulcers. A 30-item questionnaire concerning partial and full thickness pressure ulcers on the sacrum, trochanter and heel was sent to 272 wound/ET nurses. Total response rate was 32.3% with 74 analyzable questionnaires returned. Data was analyzed using descriptive statistics and correlations where appropriate. Results were: (1) The longer respondents thought it would take for wounds to heal, the more variable their responses. (2) Respondents viewed heel wounds as taking the longest to heal and were more certain about time to healing in sacral wounds. (3) Responses indicated longer healing times than those shown in recent studies looking at change in wound surface area. (4) Results on time of 3.2 weeks to autolytic debridement of wounds with black eschar does not differ greatly from published time for enzymatic debridement, in spite of guidelines stating that autolysis may take longer than other methods. This study demonstrates that there remains variability in wound nurses' perceptions of time to healing and, therefore, recent attempts at defining critical pathways may be premature.

Entities:  

Mesh:

Year:  1996        PMID: 8826137

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  1 in total

Review 1.  Heel Pressure Injuries: Consensus-Based Recommendations for Assessment and Management.

Authors:  Massimo Rivolo; Sara Dionisi; Diletta Olivari; Guido Ciprandi; Serena Crucianelli; Silvia Marcadelli; Rosa Rita Zortea; Fabio Bellini; Matteo Martinato; Armando Gabrielli; Giovanni Pomponio
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-21       Impact factor: 4.730

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.